We are live on ! Find out more
HAM

HHR Asset Management Portfolio holdings

AUM $552M
1-Year Est. Return 15.61%
This Fund
S&P 500
This Quarter Est. Return
+19.53%
1 Year Est. Return
-15.61%
3 Year Est. Return
+76.29%
5 Year Est. Return
+157.16%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
-$31M
Cap. Flow %
-2.65%
Top 10 Hldgs %
42.6%
Holding
40
New
4
Increased
8
Reduced
28
Closed
–

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$62.3M
2
AYX
Alteryx Inc
AYX
+$49.4M
3
EVBG
Everbridge, Inc. Common Stock
EVBG
+$40.1M
4
PD icon
PagerDuty
PD
+$13.6M
5
CRM icon
Salesforce
CRM
+$8.76M

Top Sells

Rank Stock Value
1
HEI icon
HEICO Corp
HEI
+$38.5M
2
SNAP icon
Snap
SNAP
+$23.2M
3
PVH icon
PVH
PVH
+$18.9M
4
FIVE icon
Five Below
FIVE
+$18.9M
5
PINS icon
Pinterest
PINS
+$17.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.28%
2 Technology 28.85%
3 Communication Services 17.68%
4 Financials 8.4%
5 Healthcare 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
26
Intuit
INTU
$88.1B
$17.3M 1.48%
45,520
-11,320
-20% -$3.98M
PD icon
27
PagerDuty
PD
$856M
$16.6M 1.42%
+398,923
New +$13.6M
SNAP icon
28
Snap
SNAP
$8.83B
$16.1M 1.38%
321,872
-559,328
-63% -$23.2M
HEI icon
29
HEICO Corp
HEI
$50.8B
$16.1M 1.38%
121,595
-315,833
-72% -$38.5M
PFPT
30
DELISTED
Proofpoint, Inc.
PFPT
$15.7M 1.34%
115,191
-40,386
-26% -$4.43M
PINS icon
31
Pinterest
PINS
$13.2B
$15.3M 1.3%
231,406
-292,524
-56% -$17.5M
CRSP icon
32
CRISPR Therapeutics
CRSP
$4.99B
$5.42M 0.46%
35,370
-12,260
-26% -$1.45M
EDIT icon
33
Editas Medicine
EDIT
$445M
$3.54M 0.3%
50,550
-17,510
-26% -$719K
SGMO
34
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.62M 0.14%
103,810
-35,950
-26% -$421K
ALLO icon
35
Allogene Therapeutics
ALLO
$680M
$1.23M 0.11%
48,650
-16,860
-26% -$550K
MGTX icon
36
MeiraGTx Holdings
MGTX
$1.18B
$1.06M 0.09%
70,306
-24,358
-26% -$344K
RGNX icon
37
Regenxbio
RGNX
$745M
$1.05M 0.09%
23,130
-8,000
-26% -$280K
QTTB icon
38
Q32 Bio
QTTB
$482M
$525K 0.04%
2,584
-895
-26% -$173K
VYGR icon
39
Voyager Therapeutics
VYGR
$189M
$446K 0.04%
62,322
-21,596
-26% -$208K
BLUE
40
DELISTED
bluebird bio
BLUE
$360K 0.03%
643
-222
-26% -$141K
1
2

Similar funds

HT
Hefren-Tillotson Pittsburgh, Pennsylvania $523M AUM 4.13% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return
TM
THRC Management Cisco, Texas $634M AUM
FC
Ferris Capital Marlborough, Massachusetts $437M AUM 8.6% 1-Year Est. Return
FC
Full18 Capital Westport, Connecticut $434M AUM 5.79% 1-Year Est. Return
VR
Viridian RIA Bothell, Washington $430M AUM 6.31% 1-Year Est. Return
MCM
Model Capital Management Wellesley, Massachusetts $422M AUM 2.75% 1-Year Est. Return

HHR Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, HHR Asset Management held 40 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HHR Asset Management's Q4 2020 filing shows 4 new, 8 increased and 28 reduced positions. Its largest new stake was Alibaba: 224,347 shares worth $52.2M. The largest sale was HEICO Corp, an estimated $38.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • HHR Asset Management's largest Q4 2020 buy was Alibaba: 224,347 shares worth $52.2M.
  • HHR Asset Management added most to Salesforce in Q4 2020, an estimated $8.76M increase.
  • HHR Asset Management's biggest Q4 2020 reduction was HEICO Corp, cutting an estimated $38.5M.
  • HHR Asset Management's ten largest holdings make up 43% of its $1.17B portfolio in Q4 2020.
  • HHR Asset Management opened 4 new positions and closed 0 in Q4 2020.
  • HHR Asset Management's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on HHR Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.